Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | December 29, 2011 | December 21, 2012 |
| AbbVie Inc.ABBV · Entity 2800 | Director | March 31, 2025 | April 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 29, 2011 · Filed December 21, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 49,432 |
Reported balance
After 2011-12-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2011-12-29 · Gift · Disposed 24,982 · Balance 49,432 F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16.
AbbVie Inc.
Report date March 31, 2025 · Filed April 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 386,479 |
Reported balance
After 2025-03-31 transaction · row 1
1 source rowRow 1 · 2025-03-31 · Gift · Disposed 2,450 · Balance 386,479 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $64.85 | $19,455.75 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 18 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 517,566 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 14,488 | $64.85 | $939,546.80 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 17 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 517,866 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,200 | $64.85 | $77,814.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 16 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 532,354 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 400 | $64.84 | $25,937.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 15 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533,554 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,100 | $64.84 | $136,164.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 14 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533,954 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 600 | $64.84 | $38,901.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 13 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,054 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 3,900 | $64.83 | $252,837.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 12 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,654 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,500 | $64.82 | $162,050.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 11 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,554 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,400 | $64.82 | $90,741.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 10 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 543,054 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,300 | $64.81 | $84,253.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 9 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 544,454 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $64.80 | $6,480.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,754 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $64.79 | $19,437.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,854 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $64.77 | $6,477.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 546,154 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 900 | $64.76 | $58,284.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 546,254 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,500 | $64.75 | $161,875.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 547,154 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $64.75 | $6,474.75 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 549,654 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 506 | $64.75 | $32,760.97 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 549,754 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 4,400 | $64.74 | $284,856.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,260 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 600 | $64.96 | $38,976.00 |
DisclosureSEC source: 0001179110-15-006876 · edgar.xml · nonDerivative · entry 9 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,147 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $64.95 | $19,485.00 |
DisclosureSEC source: 0001179110-15-006876 · edgar.xml · nonDerivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,747 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $64.94 | $19,482.00 |
DisclosureSEC source: 0001179110-15-006876 · edgar.xml · nonDerivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,047 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,300 | $64.93 | $84,409.00 |
DisclosureSEC source: 0001179110-15-006876 · edgar.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,347 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $64.92 | $19,476.00 |
DisclosureSEC source: 0001179110-15-006876 · edgar.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 484,647 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,000 | $64.92 | $64,915.00 |
DisclosureSEC source: 0001179110-15-006876 · edgar.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 484,947 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 223 | $64.91 | $14,474.93 |
DisclosureSEC source: 0001179110-15-006876 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,947 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,300 | $64.91 | $84,376.50 |
DisclosureSEC source: 0001179110-15-006876 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 486,170 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,958 | $64.90 | $191,974.20 |
DisclosureSEC source: 0001179110-15-006876 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,470 Read SEC document |
| April 08, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 6,994 | $64.72 | $452,651.68 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 25 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561,360 Read SEC document |
| April 08, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,300 | $64.87 | $84,331.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 24 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,397 Read SEC document |
| February 28, 2015 Filed Mar 3, 2015 18:15 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 24,825 | $60.50 | $1,501,912.50 |
DisclosureSEC source: 0001179110-15-004100 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,147 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 18:15 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 43,784 | $60.52 | $2,649,807.68 |
DisclosureSEC source: 0001179110-15-004100 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506,972 Read SEC document |
| February 19, 2015 Filed Feb 23, 2015 17:09 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 327,290 | $0.00 Strike: $58.88 | $0.00 |
DisclosureSEC source: 0001179110-15-003162 · edgar.xml · derivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,290 Underlying: Common stock · 327,290 shares Expires 2025-02-18 F2 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 109,097 on 02/19/2016, 109,096 on 02/19/2017, and 109,097 on 02/19/2018. Read SEC document |
| February 19, 2015 Filed Feb 23, 2015 17:09 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 165,590 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003162 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 551,918 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 04, 2015 Filed Mar 3, 2015 18:15 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-004100 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,756 F1 · balance_after: Reflects the transfer of 1,238 shares of AbbVie stock that was exempt from Section 16. Read SEC document |
| March 18, 2014 Filed Nov 26, 2014 17:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 9,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-017219 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,328 Read SEC document |
| March 04, 2014 Filed Mar 4, 2014 17:13 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 500 | $51.21 | $25,607.00 |
DisclosureSEC source: 0001179110-14-004333 · edgar.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,403 Read SEC document |
| March 04, 2014 Filed Mar 4, 2014 17:13 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,230 | $51.20 | $114,176.00 |
DisclosureSEC source: 0001179110-14-004333 · edgar.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,903 Read SEC document |
| March 04, 2014 Filed Mar 4, 2014 17:13 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,800 | $51.20 | $92,152.80 |
DisclosureSEC source: 0001179110-14-004333 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,133 Read SEC document |
| March 04, 2014 Filed Mar 4, 2014 17:13 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 269 | $51.19 | $13,770.11 |
DisclosureSEC source: 0001179110-14-004333 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,933 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 17:13 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 46,811 | $50.91 | $2,383,148.01 |
DisclosureSEC source: 0001179110-14-004333 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,202 Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 17:07 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 281,030 | $0.00 Strike: $51.42 | $0.00 |
DisclosureSEC source: 0001179110-14-003470 · edgar.xml · derivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,030 Underlying: Common stock · 281,030 shares Expires 2024-02-19 F2 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 93,677 on 02/20/2015, 93,676 on 02/20/2016, and 93,677 on 02/20/2017. Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 17:07 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 162,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003470 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,013 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| March 19, 2013 Filed Apr 2, 2013 17:27 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 12,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-006229 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,063 Read SEC document |
| March 19, 2013 Filed Apr 5, 2013 17:29 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-006542 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,053 Read SEC document |
| February 28, 2013 Filed Mar 4, 2013 17:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 7,716 | $36.73 | $283,408.68 |
DisclosureSEC source: 0001179110-13-004017 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,306 Read SEC document |
| February 19, 2013 Filed Feb 19, 2013 19:07 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 3,130 | $37.58 | $117,625.40 |
DisclosureSEC source: 0001179110-13-003033 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,022 Read SEC document |
| February 14, 2013 Filed Feb 19, 2013 19:07 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 526,430 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-13-003033 · edgar.xml · derivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 526,430 Underlying: Common stock · 526,430 shares Expires 2023-02-13 F2 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 175,477 on 02/14/2014, 175,476 on 02/14/2015, and 175,477 on 02/14/2016. Read SEC document |
| February 14, 2013 Filed Feb 19, 2013 19:07 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 257,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003033 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,152 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| April 06, 2012 Filed Apr 10, 2012 21:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 6,909 | $61.30 | $423,521.70 |
DisclosureSEC source: 0001179110-12-006676 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,575 Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 5,417 | $57.04 | $308,985.68 |
DisclosureSEC source: 0001179110-12-004072 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,484 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.